We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Pharmacovigilance – News and Features

News

C-Path Adopts the Rosetta Resolver® System for the Predictive Safety Testing Consortium

The Resolver system will be used as a central data management and analysis system to evaluate the safety and toxicity of drugs submitted for FDA approval.
News

Study Aims to Find which Breast Cancer Patients Need Chemotherapy

Medical College of Georgia researchers will use a test to measure a tumor's aggressiveness in more than 10,000 women to identify the patients who need chemotherapy.
News

LabCorp® and ARCA Discovery Partner to Commercialize Companion Diagnostic for Cardiovascular Personalized Medicine

Both the collaborators will develop a genetic test to aid in prescribing bucindolol, a genetically-targeted heart failure drug in development by ARCA.
News

Kaiser Permanente Unveils Genetic Research Program

Researchers aim to reveal the genetic and environmental causes behind deadly and disabling diseases.
News

Cystic Fibrosis Foundation Therapeutics to Support Copernicus with $5.2 Million

Copernicus Therapeutics will utilize the funds for the development its non-viral gene therapy for cystic fibrosis.
News

BrainStorm Cell Therapeutics Initiates Stem Cell Safety Study in Primates for Parkinson’s Disease

The Company has initiated a safety trial using an animal model of Parkinson’s disease in primates utilizing its adult stem cell technology.
News

Environmental Toxicants Like Lead, Mercury Target Stem Cells

A research study identifies a common molecular trigger for the effects of toxicant exposure.
News

Coated Nanoparticles Solve Sticky Drug-Delivery Problem

Researchers take cues from viruses to get treatment through body's protective mucus.
News

Tm Bioscience to Supply Tag-It™ Reagents for Personalized Medicine Study

Tag-It™ reagents for P450-2C9 and VKORC1 to be used in a study of patients using warfarin to evaluate the potential of genetic testing.
News

Affymetrix Signs Three Year Translational Medicine Agreement with Vanderbilt-Ingram Cancer Center

The collaboration will allow researchs to use Affymetrix GeneChip® technology to develop applications for cancer and HIV/AIDS.
Advertisement